Achieving Value in Cancer Care: the Case of Low- and Middle-Income Countries

Ajay Aggarwal, MD and Richard Sullivan, MD, PhD

By the year 2030, the number of new cancer cases worldwide is projected to rise to 21.3 million an- nually, up from the estimated 12.7 mil- lion cancer cases currently diagnosed. Of the 21.3 million new cases every year, approximately 70% will be from low- and middle-income countries (LMICs), many of which lack the healthcare programs required to effectively manage their current cancer burden, much less that predicted for 2030. Moreover, the ratio of mortality to incidence will continue to be significantly higher in LMICs (64% to 75%) than in high-income countries (46%).

#
July 11, 2006
#
September 06, 2007
#
March 14, 2015
#
September 30, 2007
#
May 01, 2008
#
June 04, 2008
#
July 11, 2008
#
March 08, 2009
#
December 14, 2009
#
February 09, 2011
#
September 30, 2011
#
January 01, 2012
#
February 09, 2012
#
March 16, 2015
#
April 06, 2013
#
June 27, 2013
#
October 30, 2013
#
October 30, 2013
#
March 16, 2015
#
April 15, 2014
#
April 15, 2014
#
April 15, 2014
#
April 15, 2014
#
December 02, 2014
#
December 02, 2014
#
December 01, 2014
#
December 02, 2014
#
December 02, 2014
#
March 12, 2014
#
December 02, 2014
#
December 02, 2014
#
March 14, 2015